Ed Griffen

1.6k total citations
15 papers, 775 citations indexed

About

Ed Griffen is a scholar working on Computational Theory and Mathematics, Molecular Biology and Pharmacology. According to data from OpenAlex, Ed Griffen has authored 15 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Computational Theory and Mathematics, 6 papers in Molecular Biology and 5 papers in Pharmacology. Recurrent topics in Ed Griffen's work include Computational Drug Discovery Methods (8 papers), Microbial Natural Products and Biosynthesis (3 papers) and Analytical Chemistry and Chromatography (3 papers). Ed Griffen is often cited by papers focused on Computational Drug Discovery Methods (8 papers), Microbial Natural Products and Biosynthesis (3 papers) and Analytical Chemistry and Chromatography (3 papers). Ed Griffen collaborates with scholars based in United Kingdom, United States and Switzerland. Ed Griffen's co-authors include Andrew G. Leach, Daniel J. Warner, Graeme R. Robb, Alexander G. Dossetter, Jeremy N. Burrows, Michael M. Hann, Andrew R. Leach, Stephen A. St-Gallay, Adam B. Shapiro and Hitesh J. Sanganee and has published in prestigious journals such as Nature, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Ed Griffen

15 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ed Griffen United Kingdom	11	482	434	215	124	110	15	775
John H. Van Drie United States	14	550 1.1×	505 1.2×	156 0.7×	98 0.8×	97 0.9×	21	847
David A. Cosgrove United Kingdom	13	457 0.9×	396 0.9×	118 0.5×	137 1.1×	104 0.9×	22	654
Mehran Jalaie United States	16	312 0.6×	454 1.0×	218 1.0×	95 0.8×	97 0.9×	25	794
Tuomo Kalliokoski Finland	14	470 1.0×	509 1.2×	208 1.0×	118 1.0×	51 0.5×	23	803
Mike Hann United Kingdom	4	393 0.8×	374 0.9×	146 0.7×	68 0.5×	80 0.7×	6	628
Florence L. Stahura United States	16	605 1.3×	526 1.2×	138 0.6×	122 1.0×	160 1.5×	30	832
Man‐Ling Lee Germany	12	384 0.8×	399 0.9×	155 0.7×	84 0.7×	75 0.7×	17	629
Richard J. Hall United Kingdom	14	392 0.8×	502 1.2×	200 0.9×	163 1.3×	70 0.6×	24	854
Nikolay Savchuk United States	16	569 1.2×	460 1.1×	152 0.7×	134 1.1×	199 1.8×	31	911
Edward P. Jaeger United States	13	442 0.9×	532 1.2×	166 0.8×	117 0.9×	76 0.7×	22	820

Countries citing papers authored by Ed Griffen

Since Specialization

Citations

This map shows the geographic impact of Ed Griffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ed Griffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ed Griffen more than expected).

Fields of papers citing papers by Ed Griffen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ed Griffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ed Griffen. The network helps show where Ed Griffen may publish in the future.

Co-authorship network of co-authors of Ed Griffen

This figure shows the co-authorship network connecting the top 25 collaborators of Ed Griffen. A scholar is included among the top collaborators of Ed Griffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ed Griffen. Ed Griffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Dossetter, Alexander G., et al.. (2021). Small molecule Son of Sevenless 1 (SOS1) inhibitors: a review of the patent literature. Expert Opinion on Therapeutic Patents. 31(12). 1189–1204. 22 indexed citations

Enoch, Steven J., et al.. (2021). Mapping Ligand-Shape Space for Protein–Ligand Systems: Distinguishing Key-in-Lock and Hand-in-Glove Proteins. Journal of Chemical Information and Modeling. 61(4). 1859–1874. 2 indexed citations

Delft, F. von, Mark Calmiano, John D. Chodera, et al.. (2021). A white-knuckle ride of open COVID drug discovery. Nature. 594(7863). 330–332. 16 indexed citations

Griffen, Ed, Alexander G. Dossetter, & Andrew G. Leach. (2020). Chemists: AI Is Here; Unite To Get the Benefits. Journal of Medicinal Chemistry. 63(16). 8695–8704. 27 indexed citations

Krämer, Christian, Attilla Ting, Hao Zheng, et al.. (2017). Learning Medicinal Chemistry Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Rules from Cross-Company Matched Molecular Pairs Analysis (MMPA). Journal of Medicinal Chemistry. 61(8). 3277–3292. 67 indexed citations

Colley, Helen, Munitta Muthana, Sarah Danson, et al.. (2015). An Orally Bioavailable, Indole-3-glyoxylamide Based Series of Tubulin Polymerization Inhibitors Showing Tumor Growth Inhibition in a Mouse Xenograft Model of Head and Neck Cancer. Journal of Medicinal Chemistry. 58(23). 9309–9333. 46 indexed citations

Dossetter, Alexander G., Ed Griffen, & Andrew G. Leach. (2013). Matched Molecular Pair Analysis in drug discovery. Drug Discovery Today. 18(15-16). 724–731. 112 indexed citations

Griffen, Ed, Andrew G. Leach, Graeme R. Robb, & Daniel J. Warner. (2011). Matched Molecular Pairs as a Medicinal Chemistry Tool. Journal of Medicinal Chemistry. 54(22). 7739–7750. 202 indexed citations

Kettle, Jason G., Richard A. Ward, & Ed Griffen. (2010). Data-mining patent literature for novel chemical reagents for use in medicinal chemistry design. MedChemComm. 1(5). 331–331. 7 indexed citations

10.

Warner, Daniel J., Ed Griffen, & Stephen A. St-Gallay. (2010). WizePairZ: A Novel Algorithm to Identify, Encode, and Exploit Matched Molecular Pairs with Unspecified Cores in Medicinal Chemistry. Journal of Chemical Information and Modeling. 50(8). 1350–1357. 53 indexed citations

11.

Luke, Richard, Ed Griffen, Neil J. Hales, et al.. (2009). In vitro pharmacological profiles of kinase inhibitors: Comparison with other pharmaceuticals. Journal of Pharmacological and Toxicological Methods. 60(2). 219–219. 1 indexed citations

12.

Albert, Jeffrey S., Niklas Blomberg, Alexander L. Breeze, et al.. (2007). An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes. Current Topics in Medicinal Chemistry. 7(16). 1600–1629. 91 indexed citations

13.

Leach, Andrew R., Michael M. Hann, Jeremy N. Burrows, & Ed Griffen. (2006). Fragment screening: an introduction. Molecular BioSystems. 2(9). 429–446. 116 indexed citations

14.

Griffen, Ed, et al.. (2006). An enantioselective desymmetrisation approach to C9-substituted trans-hydrindene rings based on a diastereotopic group-selective intramolecular Diels–Alder reaction. Chemical Communications. 4909–4911. 3 indexed citations

15.

Norton, David L., Richard J. Whitby, & Ed Griffen. (2004). Insertion of (E)-(1,2-dihalovinyl)lithium and (2-haloethynyl)lithium into zirconacycles. Chemical Communications. 1214–1214. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact